Immunolocalization of Receptor Activator of NF Kappa B Ligand in rat periapical lesions

Journal of Endodontics

Volumn 31, Issue 8, 2005, Pages 574-577

  Zhang, Xiaolei ^a   Peng, Bin ^a,b  

^a WUHAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Bone resorption; Osteoclast; Periapical lesion; RANKL

Indexed keywords

EID: 23744504145     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.don.0000153839.74546.66     Document Type: Article

References (23)

1. Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 1998;9:498-521.
2. Takahashi K. Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease. Int Endod J 1998;31:311-25.
3. Kawashima N, Stashenko P. Expression of Bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999;44:55-66.
4. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-90.
5. von Stechow D, Balto K, Stashenko P, Muller R. Three-dimensional quantitation of periradicular bone destruction by micro-computed tomography. J Endod 2003;294:252-6.
6. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-9.
7. Yasuda H, Shima N, Nakagawa N, et al. A novel molecular mechanism modulating osteoclast differentiation and fusion. Bone 1999;29:109-13.
8. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
9. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-602.
10. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-4.
11. ASBMR President's Committee on Nomenclature. Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. Bone 2000;27:761-4.
12. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-57.
13. Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000;408:600-5.
14. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF. Fosl1 is a transcriptional target of c-fos during osteoclast differentiation. Nat Genet 2000;24:184-7.
15. Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Genet Dev 2001;11:527-32.
16. Stashenko P, Wang CY, Tani-Ishii N, Yu SM. Pathogenesis of induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994;78:494-502.
17. Kawamoto S, Ejiri S, Hoshi K, Nagaoka E, Ozawa H. Immunolocalization of osteoclast differentiation factor in rat periontium. Arch Oral Biol 2002;47:55-8.
18. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-23.
19. Crotti TN, Smith MD, Weedon H, et al. Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Ann Rheum Dis 2002;61:1047-54.
20. Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodont Res 2003;38:380-7.
21. Grimaud E, Soubigou L, Couillaud S, et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 2003;163:2021-31.
22. Tokuda M, Nagaoka S, Torii M. Interleukin-10 inhibits expression of interleukin-6 and -8 mRNA in human dental pulp cell cultures via nuclear factor-kappaB deactivation. J Endod 2002;28:177-80.
23. Kum KY, Park JH, Yoo YJ, Choi BK, Lee HJ, Lee SJ. The inhibitory effect of alendronate and taurine on osteoclast differentiation mediated by Porphyromonas gingivalis sonicates in vitro. J Endod 2003;29:28-30.